Global and China Infectious Vaccines Market Insights, Forecast to 2027

Global and China Infectious Vaccines Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Infectious Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Infectious Vaccines Market Size Growth Rate by Type
1.2.2 Preventive Vaccine
1.2.3 Therapeutic Vaccine
1.3 Market by Application
1.3.1 Global Infectious Vaccines Market Size Growth Rate by Application
1.3.2 Adults
1.3.3 Pediatrics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Infectious Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Infectious Vaccines Revenue 2016-2027
2.1.2 Global Infectious Vaccines Sales 2016-2027
2.2 Global Infectious Vaccines, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Infectious Vaccines Historical Market Size by Region (2016-2021)
2.3.1 Global Infectious Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Infectious Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Infectious Vaccines Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Infectious Vaccines Sales Forecast by Region (2022-2027)
2.4.2 Global Infectious Vaccines Revenue Forecast by Region (2022-2027)
3 Global Infectious Vaccines Competitor Landscape by Players
3.1 Global Top Infectious Vaccines Manufacturers by Sales
3.1.1 Global Infectious Vaccines Sales by Manufacturer (2016-2021)
3.1.2 Global Infectious Vaccines Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Infectious Vaccines Manufacturers by Revenue
3.2.1 Key Infectious Vaccines Manufacturers Covered: Ranking by Revenue
3.2.2 Global Infectious Vaccines Revenue by Manufacturers (2016-2021)
3.2.3 Global Infectious Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Infectious Vaccines Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Infectious Vaccines Revenue in 2020
3.2.6 Global Infectious Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Infectious Vaccines Price by Manufacturers
3.4 Global Infectious Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Infectious Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Infectious Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Infectious Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Infectious Vaccines Market Size by Type (2016-2021)
4.1.1 Global Infectious Vaccines Sales by Type (2016-2021)
4.1.2 Global Infectious Vaccines Revenue by Type (2016-2021)
4.1.3 Infectious Vaccines Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Infectious Vaccines Market Size Forecast by Type (2022-2027)
4.2.1 Global Infectious Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Infectious Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Infectious Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Infectious Vaccines Market Size by Application (2016-2021)
5.1.1 Global Infectious Vaccines Sales by Application (2016-2021)
5.1.2 Global Infectious Vaccines Revenue by Application (2016-2021)
5.1.3 Infectious Vaccines Price by Application (2016-2021)
5.2 Infectious Vaccines Market Size Forecast by Application (2022-2027)
5.2.1 Global Infectious Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Infectious Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Infectious Vaccines Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Infectious Vaccines Market Size YoY Growth 2016-2027
6.1.1 China Infectious Vaccines Sales YoY Growth 2016-2027
6.1.2 China Infectious Vaccines Revenue YoY Growth 2016-2027
6.1.3 China Infectious Vaccines Market Share in Global Market 2016-2027
6.2 China Infectious Vaccines Market Size by Players (International and Local Players)
6.2.1 China Top Infectious Vaccines Players by Sales (2016-2021)
6.2.2 China Top Infectious Vaccines Players by Revenue (2016-2021)
6.3 China Infectious Vaccines Historic Market Review by Type (2016-2021)
6.3.1 China Infectious Vaccines Sales Market Share by Type (2016-2021)
6.3.2 China Infectious Vaccines Revenue Market Share by Type (2016-2021)
6.3.3 China Infectious Vaccines Price by Type (2016-2021)
6.4 China Infectious Vaccines Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Infectious Vaccines Sales Forecast by Type (2022-2027)
6.4.2 China Infectious Vaccines Revenue Forecast by Type (2022-2027)
6.4.3 China Infectious Vaccines Price Forecast by Type (2022-2027)
6.5 China Infectious Vaccines Historic Market Review by Application (2016-2021)
6.5.1 China Infectious Vaccines Sales Market Share by Application (2016-2021)
6.5.2 China Infectious Vaccines Revenue Market Share by Application (2016-2021)
6.5.3 China Infectious Vaccines Price by Application (2016-2021)
6.6 China Infectious Vaccines Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Infectious Vaccines Sales Forecast by Application (2022-2027)
6.6.2 China Infectious Vaccines Revenue Forecast by Application (2022-2027)
6.6.3 China Infectious Vaccines Price Forecast by Application (2022-2027)
7 North America
7.1 North America Infectious Vaccines Market Size YoY Growth 2016-2027
7.2 North America Infectious Vaccines Market Facts & Figures by Country
7.2.1 North America Infectious Vaccines Sales by Country (2016-2021)
7.2.2 North America Infectious Vaccines Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Infectious Vaccines Market Size YoY Growth 2016-2027
8.2 Asia Pacific Infectious Vaccines Market Facts & Figures by Region
8.2.1 Asia Pacific Infectious Vaccines Sales by Region (2016-2021)
8.2.2 Asia Pacific Infectious Vaccines Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Infectious Vaccines Market Size YoY Growth 2016-2027
9.2 Europe Infectious Vaccines Market Facts & Figures by Country
9.2.1 Europe Infectious Vaccines Sales by Country (2016-2021)
9.2.2 Europe Infectious Vaccines Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Infectious Vaccines Market Size YoY Growth 2016-2027
10.2 Latin America Infectious Vaccines Market Facts & Figures by Country
10.2.1 Latin America Infectious Vaccines Sales by Country (2016-2021)
10.2.2 Latin America Infectious Vaccines Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Infectious Vaccines Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Infectious Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Infectious Vaccines Sales by Country (2016-2021)
11.2.2 Middle East and Africa Infectious Vaccines Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 CSL Limited (Australia)
12.1.1 CSL Limited (Australia) Corporation Information
12.1.2 CSL Limited (Australia) Description and Business Overview
12.1.3 CSL Limited (Australia) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CSL Limited (Australia) Infectious Vaccines Products Offered
12.1.5 CSL Limited (Australia) Recent Development
12.2 Bavarian Nordic (Denmark)
12.2.1 Bavarian Nordic (Denmark) Corporation Information
12.2.2 Bavarian Nordic (Denmark) Description and Business Overview
12.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bavarian Nordic (Denmark) Infectious Vaccines Products Offered
12.2.5 Bavarian Nordic (Denmark) Recent Development
12.3 GlaxoSmithKline plc. (U.K.)
12.3.1 GlaxoSmithKline plc. (U.K.) Corporation Information
12.3.2 GlaxoSmithKline plc. (U.K.) Description and Business Overview
12.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Products Offered
12.3.5 GlaxoSmithKline plc. (U.K.) Recent Development
12.4 Emergent Bio Solutions Inc. (U.S.)
12.4.1 Emergent Bio Solutions Inc. (U.S.) Corporation Information
12.4.2 Emergent Bio Solutions Inc. (U.S.) Description and Business Overview
12.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Products Offered
12.4.5 Emergent Bio Solutions Inc. (U.S.) Recent Development
12.5 MedImmune LLC (U.S.)
12.5.1 MedImmune LLC (U.S.) Corporation Information
12.5.2 MedImmune LLC (U.S.) Description and Business Overview
12.5.3 MedImmune LLC (U.S.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 MedImmune LLC (U.S.) Infectious Vaccines Products Offered
12.5.5 MedImmune LLC (U.S.) Recent Development
12.6 Johnson and Johnson (U.S.)
12.6.1 Johnson and Johnson (U.S.) Corporation Information
12.6.2 Johnson and Johnson (U.S.) Description and Business Overview
12.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Johnson and Johnson (U.S.) Infectious Vaccines Products Offered
12.6.5 Johnson and Johnson (U.S.) Recent Development
12.7 Novartis AG (Switzerland)
12.7.1 Novartis AG (Switzerland) Corporation Information
12.7.2 Novartis AG (Switzerland) Description and Business Overview
12.7.3 Novartis AG (Switzerland) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Novartis AG (Switzerland) Infectious Vaccines Products Offered
12.7.5 Novartis AG (Switzerland) Recent Development
12.8 Merck and Company (U.S.)
12.8.1 Merck and Company (U.S.) Corporation Information
12.8.2 Merck and Company (U.S.) Description and Business Overview
12.8.3 Merck and Company (U.S.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Merck and Company (U.S.) Infectious Vaccines Products Offered
12.8.5 Merck and Company (U.S.) Recent Development
12.9 Sanofi Pasteur (France)
12.9.1 Sanofi Pasteur (France) Corporation Information
12.9.2 Sanofi Pasteur (France) Description and Business Overview
12.9.3 Sanofi Pasteur (France) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sanofi Pasteur (France) Infectious Vaccines Products Offered
12.9.5 Sanofi Pasteur (France) Recent Development
12.10 Pfizer Inc. (U.S.)
12.10.1 Pfizer Inc. (U.S.) Corporation Information
12.10.2 Pfizer Inc. (U.S.) Description and Business Overview
12.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Pfizer Inc. (U.S.) Infectious Vaccines Products Offered
12.10.5 Pfizer Inc. (U.S.) Recent Development
12.11 CSL Limited (Australia)
12.11.1 CSL Limited (Australia) Corporation Information
12.11.2 CSL Limited (Australia) Description and Business Overview
12.11.3 CSL Limited (Australia) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 CSL Limited (Australia) Infectious Vaccines Products Offered
12.11.5 CSL Limited (Australia) Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Infectious Vaccines Industry Trends
13.2 Infectious Vaccines Market Drivers
13.3 Infectious Vaccines Market Challenges
13.4 Infectious Vaccines Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Infectious Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Infectious Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Preventive Vaccine
Table 3. Major Manufacturers of Therapeutic Vaccine
Table 4. Global Infectious Vaccines Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Infectious Vaccines Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Infectious Vaccines Sales by Regions (2016-2021) & (K Units)
Table 7. Global Infectious Vaccines Sales Market Share by Regions (2016-2021)
Table 8. Global Infectious Vaccines Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Infectious Vaccines Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Infectious Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Infectious Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Infectious Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Infectious Vaccines Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Infectious Vaccines Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Infectious Vaccines Manufacturers by Revenue (US$ Million) in 2020
Table 16. Infectious Vaccines Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Infectious Vaccines Revenue Share by Manufacturers (2016-2021)
Table 18. Global Infectious Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Infectious Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Vaccines as of 2020)
Table 20. Key Manufacturers Infectious Vaccines Price (2016-2021) (USD/Unit)
Table 21. Infectious Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Infectious Vaccines Product Type
Table 23. Date of International Manufacturers Enter into Infectious Vaccines Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Infectious Vaccines Sales by Type (2016-2021) (K Units)
Table 26. Global Infectious Vaccines Sales Share by Type (2016-2021)
Table 27. Global Infectious Vaccines Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Infectious Vaccines Revenue Share by Type (2016-2021)
Table 29. Infectious Vaccines Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 30. Global Infectious Vaccines Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Infectious Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Infectious Vaccines Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Infectious Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Infectious Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global Infectious Vaccines Sales by Application (2016-2021) (K Units)
Table 36. Global Infectious Vaccines Sales Share by Application (2016-2021)
Table 37. Global Infectious Vaccines Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Infectious Vaccines Revenue Share by Application (2016-2021)
Table 39. Infectious Vaccines Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global Infectious Vaccines Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Infectious Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Infectious Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Infectious Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Infectious Vaccines Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. China Infectious Vaccines Sales (K Units) of Key Companies (2016-2021)
Table 46. China Infectious Vaccines Sales Share by Company (2016-2021)
Table 47. China Infectious Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 48. China Infectious Vaccines Revenue Share by Company (2016-2021)
Table 49. China Infectious Vaccines Sales (K Units) by Type (2016-2021)
Table 50. China Infectious Vaccines Sales Share by Type (2016-2021)
Table 51. China Infectious Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Infectious Vaccines Price (USD/Unit) by Type (2016-2021)
Table 53. China Infectious Vaccines Sales (K Units) by Type (2022-2027)
Table 54. China Infectious Vaccines Sales Share by Type (2022-2027)
Table 55. China Infectious Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Infectious Vaccines Revenue Share by Type (2022-2027)
Table 57. China Infectious Vaccines Price (USD/Unit) by Type (2022-2027)
Table 58. China Infectious Vaccines Sales (K Units) by Application (2016-2021)
Table 59. China Infectious Vaccines Sales Share by Application (2016-2021)
Table 60. China Infectious Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Infectious Vaccines Price (USD/Unit) by Application (2016-2021)
Table 62. China Infectious Vaccines Sales (K Units) by Application (2022-2027)
Table 63. China Infectious Vaccines Sales Share by Application (2022-2027)
Table 64. China Infectious Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Infectious Vaccines Revenue Share by Application (2022-2027)
Table 66. China Infectious Vaccines Price (USD/Unit) by Application (2022-2027)
Table 67. North America Infectious Vaccines Sales by Country (2016-2021) & (K Units)
Table 68. North America Infectious Vaccines Sales Market Share by Country (2016-2021)
Table 69. North America Infectious Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Infectious Vaccines Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Infectious Vaccines Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Infectious Vaccines Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Infectious Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Infectious Vaccines Revenue Market Share by Region (2016-2021)
Table 75. Europe Infectious Vaccines Sales by Country (2016-2021) & (K Units)
Table 76. Europe Infectious Vaccines Sales Market Share by Country (2016-2021)
Table 77. Europe Infectious Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Infectious Vaccines Revenue Market Share by Country (2016-2021)
Table 79. Latin America Infectious Vaccines Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Infectious Vaccines Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Infectious Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Infectious Vaccines Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Infectious Vaccines Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Infectious Vaccines Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Infectious Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Infectious Vaccines Revenue Market Share by Country (2016-2021)
Table 87. CSL Limited (Australia) Corporation Information
Table 88. CSL Limited (Australia) Description and Business Overview
Table 89. CSL Limited (Australia) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. CSL Limited (Australia) Infectious Vaccines Product
Table 91. CSL Limited (Australia) Recent Development
Table 92. Bavarian Nordic (Denmark) Corporation Information
Table 93. Bavarian Nordic (Denmark) Description and Business Overview
Table 94. Bavarian Nordic (Denmark) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. Bavarian Nordic (Denmark) Product
Table 96. Bavarian Nordic (Denmark) Recent Development
Table 97. GlaxoSmithKline plc. (U.K.) Corporation Information
Table 98. GlaxoSmithKline plc. (U.K.) Description and Business Overview
Table 99. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. GlaxoSmithKline plc. (U.K.) Product
Table 101. GlaxoSmithKline plc. (U.K.) Recent Development
Table 102. Emergent Bio Solutions Inc. (U.S.) Corporation Information
Table 103. Emergent Bio Solutions Inc. (U.S.) Description and Business Overview
Table 104. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Emergent Bio Solutions Inc. (U.S.) Product
Table 106. Emergent Bio Solutions Inc. (U.S.) Recent Development
Table 107. MedImmune LLC (U.S.) Corporation Information
Table 108. MedImmune LLC (U.S.) Description and Business Overview
Table 109. MedImmune LLC (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. MedImmune LLC (U.S.) Product
Table 111. MedImmune LLC (U.S.) Recent Development
Table 112. Johnson and Johnson (U.S.) Corporation Information
Table 113. Johnson and Johnson (U.S.) Description and Business Overview
Table 114. Johnson and Johnson (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Johnson and Johnson (U.S.) Product
Table 116. Johnson and Johnson (U.S.) Recent Development
Table 117. Novartis AG (Switzerland) Corporation Information
Table 118. Novartis AG (Switzerland) Description and Business Overview
Table 119. Novartis AG (Switzerland) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. Novartis AG (Switzerland) Product
Table 121. Novartis AG (Switzerland) Recent Development
Table 122. Merck and Company (U.S.) Corporation Information
Table 123. Merck and Company (U.S.) Description and Business Overview
Table 124. Merck and Company (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. Merck and Company (U.S.) Product
Table 126. Merck and Company (U.S.) Recent Development
Table 127. Sanofi Pasteur (France) Corporation Information
Table 128. Sanofi Pasteur (France) Description and Business Overview
Table 129. Sanofi Pasteur (France) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Sanofi Pasteur (France) Product
Table 131. Sanofi Pasteur (France) Recent Development
Table 132. Pfizer Inc. (U.S.) Corporation Information
Table 133. Pfizer Inc. (U.S.) Description and Business Overview
Table 134. Pfizer Inc. (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. Pfizer Inc. (U.S.) Product
Table 136. Pfizer Inc. (U.S.) Recent Development
Table 137. Infectious Vaccines Market Trends
Table 138. Infectious Vaccines Market Drivers
Table 139. Infectious Vaccines Market Challenges
Table 140. Infectious Vaccines Market Restraints
Table 141. Infectious Vaccines Customers List
Table 142. Infectious Vaccines Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Infectious Vaccines Product Picture
Figure 2. Global Infectious Vaccines Sales Market Share by Type in 2020 & 2027
Figure 3. Preventive Vaccine Product Picture
Figure 4. Therapeutic Vaccine Product Picture
Figure 5. Global Infectious Vaccines Sales Market Share by Application in 2020 & 2027
Figure 6. Adults
Figure 7. Pediatrics
Figure 8. Infectious Vaccines Report Years Considered
Figure 9. Global Infectious Vaccines Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Infectious Vaccines Market Size 2016-2027 (US$ Million)
Figure 11. Global Infectious Vaccines Sales 2016-2027 (K Units)
Figure 12. Global Infectious Vaccines Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Infectious Vaccines Sales Market Share by Region (2016-2021)
Figure 14. Global Infectious Vaccines Sales Market Share by Region in 2020
Figure 15. Global Infectious Vaccines Revenue Market Share by Region (2016-2021)
Figure 16. Global Infectious Vaccines Revenue Market Share by Region in 2020
Figure 17. Global Infectious Vaccines Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Infectious Vaccines Revenue in 2020
Figure 19. Infectious Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Infectious Vaccines Sales Market Share by Type (2016-2021)
Figure 21. Global Infectious Vaccines Sales Market Share by Type in 2020
Figure 22. Global Infectious Vaccines Revenue Market Share by Type (2016-2021)
Figure 23. Global Infectious Vaccines Revenue Market Share by Type in 2020
Figure 24. Global Infectious Vaccines Sales Market Share by Application (2016-2021)
Figure 25. Global Infectious Vaccines Sales Market Share by Application in 2020
Figure 26. Global Infectious Vaccines Revenue Market Share by Application (2016-2021)
Figure 27. Global Infectious Vaccines Revenue Market Share by Application in 2020
Figure 28. China Infectious Vaccines Sales Growth Rate 2016-2027 (K Units)
Figure 29. China Infectious Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. China Infectious Vaccines Market Share in Global Market 2016-2027
Figure 31. China 5 and 10 Largest Infectious Vaccines Players Market Share by Revenue in Infectious Vaccines in 2020
Figure 32. China Infectious Vaccines Revenue Share by Type (2016-2021)
Figure 33. China Infectious Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 34. China Infectious Vaccines Revenue Share by Application (2016-2021)
Figure 35. China Infectious Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Infectious Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 37. North America Infectious Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Infectious Vaccines Sales Market Share by Country in 2020
Figure 39. North America Infectious Vaccines Revenue Market Share by Country in 2020
Figure 40. U.S. Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 41. U.S. Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 43. Canada Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Infectious Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 45. Europe Infectious Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Infectious Vaccines Sales Market Share by Country in 2020
Figure 47. Europe Infectious Vaccines Revenue Market Share by Country in 2020
Figure 48. Germany Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 49. Germany Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 51. France Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 53. U.K. Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 55. Italy Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 57. Russia Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Infectious Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 59. Asia Pacific Infectious Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Infectious Vaccines Sales Market Share by Region in 2020
Figure 61. Asia Pacific Infectious Vaccines Revenue Market Share by Region in 2020
Figure 62. China Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 63. China Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 65. Japan Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 67. South Korea Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 69. India Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 71. Australia Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Taiwan Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 73. Taiwan Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 75. Indonesia Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 77. Thailand Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 79. Malaysia Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Philippines Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 81. Philippines Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Vietnam Infectious Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 83. Vietnam Infectious Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Infectious Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 85. Latin America Infectious Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Infectious Vaccines Sales Market Share by Country in 2020
Figure

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs